Cargando…
Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?
A rapidly progressive and crescentic IgA nephropathy (IgAN) is uncommon, but it has a high risk of progression to end-stage renal disease and variable response to immunosuppression. The importance of a positive anti-neutrophil cytoplasmic antibody (ANCA) serology in this group of patients is not ful...
Autores principales: | Rojas-Rivera, Jorge, Fernández-Juárez, Gema, Praga, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581398/ https://www.ncbi.nlm.nih.gov/pubmed/26413269 http://dx.doi.org/10.1093/ckj/sfv095 |
Ejemplares similares
-
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus–Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study
por: Rojas-Rivera, Jorge, et al.
Publicado: (2015) -
Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy
por: Haruhara, Kotaro, et al.
Publicado: (2015) -
Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?
por: Ring, Troels, et al.
Publicado: (2015) -
Targeting complement in IgA nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023) -
Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case–control study
por: Yang, Ya-zi, et al.
Publicado: (2015)